157 related articles for article (PubMed ID: 37852561)
21. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L
BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857
[TBL] [Abstract][Full Text] [Related]
22. Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn's Disease Treated with Anti-Tumour Necrosis Factor Therapy.
Messadeg L; Hordonneau C; Bouguen G; Goutorbe F; Reimund JM; Goutte M; Boucher AL; Scanzi J; Reymond M; Allimant C; Dapoigny M; Pereira B; Bommelaer G; Buisson A
J Crohns Colitis; 2020 Nov; 14(11):1524-1534. PubMed ID: 32533769
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of ultrasonography for small intestinal evaluations in pediatric Crohn's disease.
Okuhira T; Yoden A; Kaji E; Otani-Akamatsu M; Inoue K; Aomatsu T; Takitani K; Ashida A
Pediatr Int; 2022 Jan; 64(1):e15206. PubMed ID: 35704459
[TBL] [Abstract][Full Text] [Related]
24. Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn's Disease.
Ordás I; Rimola J; Alfaro I; Rodríguez S; Castro-Poceiro J; Ramírez-Morros A; Gallego M; Giner À; Barastegui R; Fernández-Clotet A; Masamunt M; Ricart E; Panés J
Gastroenterology; 2019 Aug; 157(2):432-439.e1. PubMed ID: 30953614
[TBL] [Abstract][Full Text] [Related]
25. Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease.
Danese S; Sandborn WJ; Colombel JF; Vermeire S; Glover SC; Rimola J; Siegelman J; Jones S; Bornstein JD; Feagan BG
Gastroenterology; 2019 Oct; 157(4):1007-1018.e7. PubMed ID: 31279871
[TBL] [Abstract][Full Text] [Related]
26. Qualitative sonographic assessment of transmural ileal inflammation in Crohn's disease: a comparison with MRI activity score.
Livne M; Amitai MM; Klang E; Ben Horin S; Ungar B; Levartovsky A; Kopylov U; Carter D
Eur J Gastroenterol Hepatol; 2021 Jul; 33(7):961-966. PubMed ID: 33439603
[TBL] [Abstract][Full Text] [Related]
27. Association of Faecal Calprotectin Level and Combined Endoscopic and Radiological Healing in Patients With Crohn's Disease Receiving Anti-tumour Necrosis Factor Therapy.
Noh SM; Oh EH; Park SH; Lee JB; Kim JY; Park JC; Kim J; Ham NS; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Ye BD
J Crohns Colitis; 2020 Sep; 14(9):1231-1240. PubMed ID: 32157278
[TBL] [Abstract][Full Text] [Related]
28. Cannabis for the treatment of Crohn's disease.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
[TBL] [Abstract][Full Text] [Related]
29. Baseline and Postinduction Intestinal Ultrasound Findings Predict Long-term Transmural and Mucosal Healing in Patients With Crohn's Disease.
Huang Z; Cheng W; Chao K; Tang J; Li M; Guo Q; Liu G; Gao X
Inflamm Bowel Dis; 2023 Oct; ():. PubMed ID: 37889843
[TBL] [Abstract][Full Text] [Related]
30. Development and Validation of a Simple Ultrasound Activity Score for Crohn's Disease.
Sævik F; Eriksen R; Eide GE; Gilja OH; Nylund K
J Crohns Colitis; 2021 Jan; 15(1):115-124. PubMed ID: 32504533
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance index of activity (MaRIA) and Clermont score are highly and equally effective MRI indices in detecting mucosal healing in Crohn's disease.
Buisson A; Pereira B; Goutte M; Reymond M; Allimant C; Obritin-Guilhen H; Bommelaer G; Hordonneau C
Dig Liver Dis; 2017 Nov; 49(11):1211-1217. PubMed ID: 28919192
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the extension and the inflammatory activity in Crohn's disease: comparison of ultrasound and MRI.
Martínez MJ; Ripollés T; Paredes JM; Blanc E; Martí-Bonmatí L
Abdom Imaging; 2009; 34(2):141-8. PubMed ID: 18214582
[TBL] [Abstract][Full Text] [Related]
33. Validation of the Simplified Magnetic Resonance Index of Activity [sMARIA] Without Gadolinium-enhanced Sequences for Crohn's Disease.
Capozzi N; Ordás I; Fernandez-Clotet A; Castro-Poceiro J; Rodríguez S; Alfaro I; Sapena V; Masamunt MC; Ricart E; Panés J; Rimola J
J Crohns Colitis; 2020 Sep; 14(8):1074-1081. PubMed ID: 32080712
[TBL] [Abstract][Full Text] [Related]
34. A magnetic resonance enterography index for assessing small bowel Crohn's disease activity.
Zuo Y; Huang W; Wei J; Lan X
Quant Imaging Med Surg; 2023 Apr; 13(4):2128-2142. PubMed ID: 37064394
[TBL] [Abstract][Full Text] [Related]
35. Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
Campos C; Perrey A; Lambert C; Pereira B; Goutte M; Dubois A; Goutorbe F; Dapoigny M; Bommelaer G; Hordonneau C; Buisson A
Dig Dis Sci; 2017 Jun; 62(6):1628-1636. PubMed ID: 28401425
[TBL] [Abstract][Full Text] [Related]
36. Monitoring of small bowel Crohn's disease.
Kopylov U; Koulaouzidis A; Klang E; Carter D; Ben-Horin S; Eliakim R
Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):1047-1058. PubMed ID: 28737951
[TBL] [Abstract][Full Text] [Related]
37. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.
af Björkesten CG; Nieminen U; Turunen U; Arkkila P; Sipponen T; Färkkilä M
Scand J Gastroenterol; 2012 May; 47(5):528-37. PubMed ID: 22356594
[TBL] [Abstract][Full Text] [Related]
38. Accuracy of Serum Leucine-Rich Alpha-2 Glycoprotein in Evaluating Endoscopic Disease Activity in Crohn's Disease.
Kawamura T; Yamamura T; Nakamura M; Maeda K; Sawada T; Ishikawa E; Iida T; Mizutani Y; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M
Inflamm Bowel Dis; 2023 Feb; 29(2):245-253. PubMed ID: 35436345
[TBL] [Abstract][Full Text] [Related]
39. Low dose naltrexone for induction of remission in Crohn's disease.
Segal D; Macdonald JK; Chande N
Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease.
Yang E; Panaccione N; Whitmire N; Dulai PS; Vande Casteele N; Singh S; Boland BS; Collins A; Sandborn WJ; Panaccione R; Battat R
Aliment Pharmacol Ther; 2020 Jun; 51(11):1031-1038. PubMed ID: 32329532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
